Publications by authors named "Natascha Neu"

Claim this Profile
E
Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer.
Changsong Qi, Lin Shen, Thierry Andre, Hyun Cheol Chung, Timothy L Cannon, Natascha Neu

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, Stefan Bielack, Daniel Orbach, Natascha Neu

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, Stefan Bielack, Daniel Orbach, Natascha Neu

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, Stefan Bielack, Daniel Orbach, Natascha Neu

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinol and Retinol Binding Protein 4 Levels and Cardiometabolic Disease Risk.
Catarina Schiborn, Daniela Weber, Tilman Grune, Ronald Biemann, Susanne Jäger, Natascha Neu

Circ Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis